Glaxo Smithkline Pharmaceuticals Ltd.
Click on the API name to know their properties
|Composit uses/ indication of Migrabeta Plus :|
Prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
Hypertension, Angina pectoris, Cardiac arrhythmias, Migraine, Anxiety, Portal hypertension, Essential tremor, Phaeochromocytoma, Thyrotoxicosis.
|Composit contra indication of Migrabeta Plus :|
Pregnancy, lactation, GI or urinary tract obstruction, acute porphyrias.
Acidosis, Asthma, Heart failure, Cardiogenic shock, Bronchospasm, Haemorrhage, Heart block, Pregnancy (2nd and 3rd trimesters), Lactation.
|Composit side effects of Migrabeta Plus :|
Drowsiness and depression. Heartburn, nausea, vomiting and stomach pain. Sleeplessness, dizziness, vertigo and anxiety disorder. Dry mouth, weakness, muscle aches and skin rash.
Tiredness, lack of drive, GI upsets, nightmares, forgetfulness, rarely hallucinations, muscle fatigue. Cold extremities, insomnia, dizziness. Anorexia, impotence. Thrombocytopenic purpura, agranulocytosis, nonthrombocytopenic purpura, thrombocytopenia. Depression, confusion, cognitive dysfunction.
|Composit caution of Migrabeta Plus :|
Driving or operating machinery, epilepsy, elderly, CVS disease, glaucoma.
Impaired renal and hepatic function. Cardiac failure. Myocardial insufficiency. Elderly. May mask symptoms of hyperthyroidism and hypoglycaemia. May unmask myasthenia gravis.
Franco Indian Pharmaceutical